A 45-year-old African American female presented with a four-day history of nausea, vomiting, abdominal pain and diarrhea. She had recently been started on an angiotensin converting enzyme inhibitor (ACE-I) -lisinopril, for hypertension. On examination, she had diffuse abdominal tenderness but no swelling of the lips or tongue. Laboratory tests showed mild leucocytosis and lactic acidosis. A computed tomography (CT) scan of the abdomen and pelvis showed circumferential small bowel wall edema and fold thickening with hyperenhancing mucosa and edematous submucosa resulting in mural stratification (solid arrows, A follow-up CT scan obtained four days later, showed complete resolution of bowel wall thickening, and the associated peri-enteric inflammatory changes and ascites. ACE-I have been reported to cause peripheral angioedema in 0.1% to 0.2% of patients, with visceral angioedema reported to occur even less commonly 1 . The differential diagnosis of bowel wall thickening includes ischemic bowel, shock bowel, vasculitis (e.g. Henoch-Schönlein purpura), intramural hematoma (e.g. trauma or anticoagulation therapy), infectious enteritis, medications (esp ACE-I) and inflammatory bowel disease high index of suspicion can help make the diagnosis of angioedema secondary to ACE-I and avoid the cost and morbidity associated with unnecessary interventions 4 .
